Endocyte Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.06 |
Market Cap |
$1.37 B |
Shares Outstanding |
70.01 M |
Public Float |
56.49 M |
Address |
3000 Kent Avenue West Lafayette Indiana 47906 United States |
Employees | - |
Website | http://www.endocyte.com |
Updated | 09/14/2018 |
Endocyte, Inc. is a biopharmaceutical company, which engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. |